SANDOZ PIRFENIDONE CAPSULES
SANDOZ PIRFENIDONE CAPSULES
Approved
DIN Number
02488833
Drug Class
Human
Market Date
Oct 25, 2021
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02488833
AIG Number0153328001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX05 PIRFENIDONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification48:02.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PIRFENIDONEActive
Strength: 267 MG
Monograph: PIRFENIDONE